Apogee Therapeutics, Inc.
APGE
$68.50
$1.732.59%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 14.69% | -2.07% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 9.51% | -2.58% | |||
| Operating Income | -9.51% | 2.58% | |||
| Income Before Tax | -6.72% | 1.61% | |||
| Income Tax Expenses | 1.64% | -15.28% | |||
| Earnings from Continuing Operations | -6.71% | 1.63% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -6.71% | 1.63% | |||
| EBIT | -9.51% | 2.58% | |||
| EBITDA | -9.56% | 2.60% | |||
| EPS Basic | 6.89% | 2.20% | |||
| Normalized Basic EPS | 6.89% | 2.18% | |||
| EPS Diluted | 6.89% | 2.20% | |||
| Normalized Diluted EPS | 6.89% | 2.18% | |||
| Average Basic Shares Outstanding | 14.61% | 0.59% | |||
| Average Diluted Shares Outstanding | 14.61% | 0.59% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||